Repository for the Family Investigation of Nephropathy & Diabetes
肾病家庭调查资料库
基本信息
- 批准号:10043394
- 负责人:
- 金额:$ 4.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-31 至 2020-08-30
- 项目状态:已结题
- 来源:
- 关键词:AffectCell LineChargeChronicCryopreserved CellDatabasesDiabetes MellitusDiabetic NephropathyDiseaseENG geneEnd stage renal failureFamilyGenesGenetic Predisposition to DiseaseGoalsHyperglycemiaHypertensionIndividualInstitutionInsulin-Dependent Diabetes MellitusInterventionInvestigationKidney DiseasesLinkNational Institute of Diabetes and Digestive and Kidney DiseasesNon-Insulin-Dependent Diabetes MellitusPatientsPhenotypePlasmaPredispositionPrognostic FactorResearch PersonnelSamplingSecureUrinegenetic technologypreservationrepositorysample collection
项目摘要
Diabetic nephropathy (DN) is a multifactoral disease, and a large proportion of patients affected with either type 1 or type 2 diabetes develop diabetic nephropathy and progress to end stage renal disease (ESRD). When poor prognostic factors such as hypertension and chronic hyperglycemia are aggressively treated, the rate of progression of diabetic nephropathy can be slowed. However, no interventions have been shown to reliably halt the progression of diabetic nephropathy. Numerous studies have suggested that genetic predisposition to diabetic nephropathy exists, but genes for nephropathy have not yet been isolated. It is anticipated that a comprehensive analysis of a large number of uniformly phenotyped ESRD families will be necessary to isolated genes for ESRD. Such a database of families may not be available at any single institution. The charge of the FIND consortium was to acquire sets of families and individuals with well-characterized diabetic nephropathy, establish a secure master FIND database, and use genetic technologies to identify chromosomal regions linked with diabetic nephropathy in order to identify diabetic nephropathy susceptibility or protection genes. A Repository of samples collected during the FIND is essential for the FIND study to achieve its goals and for subsequent studies of this valuable sample collection.
糖尿病肾病(DN)是一种多因素疾病,并且大部分受1型或2型糖尿病影响的患者发展为糖尿病肾病并进展为终末期肾病(ESRD)。当预后不良的因素如高血压和慢性高血糖得到积极治疗时,糖尿病肾病的进展速度可以减缓。然而,没有任何干预措施能可靠地阻止糖尿病肾病的进展。许多研究表明,糖尿病肾病的遗传易感性存在,但肾病的基因尚未分离。预计对大量的统一表型的ESRD家族进行综合分析将是分离ESRD基因所必需的。任何一个机构都可能没有这样的家庭数据库。FIND联盟的任务是获得具有良好特征的糖尿病肾病的家庭和个人的集合,建立安全的主FIND数据库,并使用遗传技术来识别与糖尿病肾病相关的染色体区域,以识别糖尿病肾病易感性或保护基因。在FIND期间收集的样本的储存库对于FIND研究实现其目标以及对这一宝贵样本收集的后续研究至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEONARD FREEDMAND其他文献
LEONARD FREEDMAND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEONARD FREEDMAND', 18)}}的其他基金
DCP - Cancer Prevention Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia) BioRepository
DCP - 癌症预防 0/I/II 期癌症预防临床试验计划(联盟)BioRepository
- 批准号:
10199869 - 财政年份:2019
- 资助金额:
$ 4.12万 - 项目类别:
TAS::75 0849::TAS INCREMENTAL FUNDING
塔斯马尼亚州::75 0849::塔斯马尼亚州增量资金
- 批准号:
10038552 - 财政年份:2019
- 资助金额:
$ 4.12万 - 项目类别:
DCP- Cancer Immunoprevention Laboratory Support
DCP-癌症免疫预防实验室支持
- 批准号:
10043975 - 财政年份:2019
- 资助金额:
$ 4.12万 - 项目类别:
DCP - COPTRG Support [National Surgical Adjuvant Breast and Bowel Project (NSABP)
DCP - COPTRG 支持 [国家乳腺和肠道辅助手术项目 (NSABP)
- 批准号:
10199862 - 财政年份:2019
- 资助金额:
$ 4.12万 - 项目类别:
Eye Exams Associated with Anetumab Ravtansine Administration
与 Anetumab Ravtansine 给药相关的眼科检查
- 批准号:
10038614 - 财政年份:2019
- 资助金额:
$ 4.12万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 4.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 4.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 4.12万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 4.12万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 4.12万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 4.12万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 4.12万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 4.12万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 4.12万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 4.12万 - 项目类别:
Studentship














{{item.name}}会员




